Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Aileron Therapeutics, Inc. (NASDAQ: ALRN).

Full DD Report for ALRN

You must become a subscriber to view this report.


Recent News from (NASDAQ: ALRN)

Aileron Therapeutics Announces Changes to Management
CAMBRIDGE, Mass., May 15, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq:ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that Joseph A. Yanchik III has resigned as President and Chief Executive Officer of&#...
Source: GlobeNewswire
Date: May, 15 2018 16:05
Aileron Therapeutics Reports First Quarter 2018 Financial Results
CAMBRIDGE, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq:ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today reported business highlights and financial results for the first quarter ended March 31, 2...
Source: GlobeNewswire
Date: May, 09 2018 16:03
After Hours Gainers / Losers (04/11/2018)
Top gainers: QNST +20.9% . BLCM +15.3% . ALRN   +4.3% . VEON   +2.1% . FTI   +1.4% . More news on: QuinStreet, Inc., Bellicum Pharmaceuticals, Aileron Therapeutics, Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: April, 11 2018 17:34
Aileron Therapeutics Announces Publication by Researchers at Albert Einstein College of Medicine of ALRN-6924 Nonclinical Data in Acute Myeloid Leukemia
CAMBRIDGE, Mass., April 11, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), the clinical stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced the publication of nonclinical results in Science Translational Medicine demonstr...
Source: GlobeNewswire
Date: April, 11 2018 16:05
Midday Gainers / Losers (04/09/2018)
Gainers:  AVXS +82% . KONE +59% . HEAR +29% . TRPX +24% . RGNX +22% . MEET +20% . HTBX +20% . QURE +18% . ALRN +18% . ABEO +16% . More news on: AveXis, Kingtone Wirelessinfo Solution Holding Ltd, Turtle Beach Corporation, Stocks on the move, , Read ...
Source: SeekingAlpha
Date: April, 09 2018 12:42
Aileron Therapeutics misses by $0.01
Aileron Therapeutics (NASDAQ: ALRN ): Q4 EPS of -$0.47 misses by $0.01 . Cash, cash equivalents and investments of $50.8M Press Release More news on: Aileron Therapeutics, Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: April, 02 2018 16:52
Aileron Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
CAMBRIDGE, Mass., April 02, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today reported business highlights and financial results for the fourth quarter and full year ended...
Source: GlobeNewswire
Date: April, 02 2018 16:08
Aileron Therapeutics Announces Expansion of Scientific Advisory Board
CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that three leading oncology experts have joined its Scientific Advisory Board (SAB)...
Source: GlobeNewswire
Date: March, 28 2018 07:00
Aileron Therapeutics Appoints Jeffrey A. Bailey to its Board of Directors
CAMBRIDGE, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), the clinical-stage leader in the field of stapled peptides developing therapeutics for cancers and other diseases, today announced the appointment of Jeffrey A. Bailey as Chairman of its Board of Direct...
Source: GlobeNewswire
Date: March, 19 2018 07:00
Daily Insider Ratings Round Up 1/11/18: ASPS, FLDM, CHN
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
Source: SeekingAlpha
Date: January, 14 2018 12:14

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-185.365.245.52925.1827,950
2018-05-175.365.245.52925.1827,950

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-254,1127,46855.0616Short
2018-05-2419,10422,08686.4982Short
2018-05-239,22010,68486.2973Short
2018-05-226,3028,32075.7452Short
2018-05-217,67612,28762.4725Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ALRN.


About Aileron Therapeutics, Inc. (NASDAQ: ALRN)

Logo for Aileron Therapeutics, Inc. (NASDAQ: ALRN)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: ALRN)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 16 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 09 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: May, 09 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 30 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 30 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 09 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: April, 02 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 19 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: February, 09 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: November, 09 2017

       

       


      Daily Technical Chart for (NASDAQ: ALRN)

      Daily Technical Chart for (NASDAQ: ALRN)


      Stay tuned for daily updates and more on (NASDAQ: ALRN)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: ALRN)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      The Subway Trader
      @TheSubwayTrader

       

       


      Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ALRN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of ALRN and does not buy, sell, or trade any shares of ALRN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/